Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,180,325
+$284,792 QoQ
Shares Held
150,334
-3.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#517
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Norinchukin Bank, The holds $196,729,984 across 9 Drug Manufacturers - General names. JNJ ranks #2 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
48,255 | $57,878,499 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
150,334 | $38,180,325 | |
| 3 | ABBV |
AbbVie Inc.
|
107,762 | $27,117,229 | |
| 4 | AMGN |
Amgen Inc
|
59,210 | $21,441,125 | |
| 5 | MRK |
Merck & Co., Inc.
|
152,112 | $19,546,392 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
120,669 | $15,245,321 | |
| 7 | PFE |
Pfizer Inc
|
338,399 | $8,148,647 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
124,541 | $7,176,052 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,180,325 | 150,334 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $37,895,533 | 155,030 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $32,312,759 | 156,138 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $27,166,625 | 146,514 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $22,376,500 | 146,491 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $22,218,248 | 133,974 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $16,987,065 | 117,460 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $17,731,146 | 109,411 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,905,808 | 95,141 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,949,587 | 94,504 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $15,432,777 | 98,461 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $17,040,140 | 109,407 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $39,550,838 | 238,949 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $28,835,115 | 186,033 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $31,988,488 | 181,084 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $36,350,703 | 222,519 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $35,685,545 | 201,034 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $47,702,517 | 269,156 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $43,086,374 | 251,864 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $41,334,471 | 255,941 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $40,362,947 | 245,010 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $39,510,233 | 240,403 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $37,778,124 | 240,044 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $36,458,032 | 244,882 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $34,165,355 | 242,945 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $34,342,029 | 261,893 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||